Published in Int J Colorectal Dis on April 01, 1986
Delay in diagnosis and treatment of symptomatic colorectal cancer. Lancet (1979) 4.91
President's address. The polyp-cancer sequence in the large bowel. Proc R Soc Med (1974) 4.90
Controlled trial of faecal occult blood testing in the detection of colorectal cancer. Lancet (1983) 3.99
Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology (1982) 3.62
Occult blood screening for colorectal carcinoma: a critical review. Gastroenterology (1985) 3.03
Aspirin and gastrointestinal bleeding. Chromate blood loss studies. Am J Med (1961) 2.97
Basic issues in population screening for cancer. J Natl Cancer Inst (1980) 2.62
The survival of patients with colorectal cancer treated in a regional hospital. Br J Surg (1978) 2.27
Progress report on controlled trial of fecal occult blood testing for the detection of colorectal neoplasia. Cancer (1980) 2.02
The earlier detection of colorectal cancers: a preliminary report of the results of the Occult Blood Study. Cancer (1980) 1.85
Immunological detection of faecal occult blood in colorectal cancer. Br J Cancer (1984) 1.84
Optimal dietary conditions for hemoccult testing. Gastroenterology (1982) 1.58
A mass screening program for colorectal cancer using chemical testing for occult blood in the stool. Cancer (1980) 1.56
Factors affecting compliance with screening for colorectal cancer. Community Med (1984) 1.52
Fecal occult blood screening for colorectal cancer in a Veterans Administration Hospital. Am J Surg (1983) 1.47
Multiphasic checkup evaluation study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Prev Med (1973) 1.46
Outcome in colorectal carcinoma: seven-year study of a population. Br Med J (1980) 1.42
Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial. Cancer (1986) 1.40
Immunochemical detection of fecal occult blood--the fecal smear punch-disc test: a new non-invasive screening test for colorectal cancer. Cancer (1980) 1.37
Fecal blood levels in health and disease. A study using HemoQuant. N Engl J Med (1985) 1.25
Mass screening for colorectal cancer. Am J Surg (1974) 1.23
Bleeding patterns in colorectal cancer: the effect of aspirin and the implications for faecal occult blood testing. Br J Surg (1982) 1.20
Accuracy of occult blood tests over a six-day period. Clin Oncol (1983) 1.19
A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer. Br J Cancer (1985) 1.19
ROUTINE CHEMICAL TESTS OF THE STOOL FOR OCCULT BLOOD: AN EVALUATION. Am J Med Sci (1965) 1.14
False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med (1975) 1.11
Colonoscopy in the detection of carcinoma of the intestine. Surg Gynecol Obstet (1979) 1.09
Fecal blood loss in patients with colonic polyps: a comparison of measurements with 51chromium-labeled erythrocytes and with the Haemoccult test. Gastroenterology (1982) 1.09
Evaluation of an immunological test for occult bleeding from colorectal neoplasia. Aust N Z J Surg (1982) 1.05
Hemoccult detection of fecal occult blood quantitated by radioassay. Am J Dig Dis (1976) 1.05
A prospective study of diagnostic methods in adenoma follow-up. Endoscopy (1982) 1.04
Immunochemical detection of human blood in feces. Am J Clin Pathol (1978) 1.00
HemoQuant, a new quantitative assay for fecal hemoglobin. Comparison with Hemoccult. Ann Intern Med (1984) 0.99
Biometric design of the Mayo Lung Project for early detection and localization of bronchogenic carcinoma. Cancer (1972) 0.97
The false-negative hemoccult test. Gastroenterology (1977) 0.97
Five guaiac-based tests for occult blood in faeces compared in vitro and in vivo. Scand J Clin Lab Invest (1984) 0.97
An immunofluorescent test for faecal occult blood. Lancet (1981) 0.96
Quantitative fecal recovery of ingested hemoglobin-heme in blood: comparisons by HemoQuant assay with ingested meat and fish. Gastroenterology (1985) 0.94
The early detection of colorectal cancer. Cancer (1977) 0.94
A control trial of faecal occult blood screening for colorectal cancer: 2-year results. Br J Surg (1985) 0.91
Hemoccult stool tests: false-negative results due to storage of specimens. Mayo Clin Proc (1976) 0.90
Surveillance for colorectal cancer in average-risk patients, familial high-risk groups, and patients with adenomas. Cancer (1982) 0.90
Comparative educational approaches to screening for colorectal cancer. Am J Public Health (1978) 0.90
Sensitivity of guaiac-impregnated cards for the detection of colorectal neoplasia. J Clin Gastroenterol (1983) 0.87
Biases in the assessment of colorectal cancer screening programmes using hemoccult. Aust N Z J Surg (1982) 0.85
Mass screening for colorectal cancer. Scand J Gastroenterol (1984) 0.85
False-positive stool occult blood tests caused by iron preparations. A controlled study and review of literature. Gastroenterology (1982) 0.82
Screening for colorectal cancer. South Med J (1979) 0.81
Peroxidase levels in food: relevance to colorectal cancer screening. Am J Clin Nutr (1982) 0.80
Hemoccult screening for colorectal cancer. An impact study on Sarasota, Florida. J Fla Med Assoc (1979) 0.80
Comparative studies on the "in vivo"-sensitivity of four commercial pseudoperoxidase-based faecal occult blood tests in relation to actual blood losses as calculated from measured whole body-59Fe-elimination rates. Klin Wochenschr (1980) 0.78
Hemoccult screening for colorectal neoplasms. Report of a mail-out project without dietary restriction in a prepaid health plan. Wis Med J (1983) 0.77
[Regional analysis of participation in the mandatory cancer detection program in 1981 in West Germany]. Offentl Gesundheitswes (1984) 0.76
Immunochemical testing for faecal occult blood in patients with colorectal cancer. Med J Aust (1985) 0.76
The feasibility of large scale population screening. Br J Surg (1985) 0.76
Screening for colorectal tumors - results of two years experience. Cancer Detect Prev (1980) 0.76
Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med (1993) 27.80
Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med (1993) 21.18
Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med (2000) 13.21
The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med (2000) 13.19
Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70
Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst (1999) 8.08
A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med (1994) 5.98
Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements. J Lab Clin Med (1975) 5.32
A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med (2000) 4.84
Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet (1989) 4.72
Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med (1999) 4.11
Studies of a flatulent patient. N Engl J Med (1976) 4.05
Factors influencing pulmonary methane excretion in man. An indirect method of studying the in situ metabolism of the methane-producing colonic bacteria. J Exp Med (1971) 3.88
Occult blood screening for colorectal carcinoma: a critical review. Gastroenterology (1985) 3.03
Early and late complications after endoscopic sphincterotomy for biliary lithiasis with and without the gall bladder 'in situ'. Gut (1984) 2.82
Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol (1999) 2.70
The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut (1999) 2.53
Use of pulmonary hydrogen (H 2 ) measurements to quantitate carbohydrate absorption. Study of partially gastrectomized patients. J Clin Invest (1972) 2.50
Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. J Natl Cancer Inst (1995) 2.49
Risk factors for severe delayed postpolypectomy bleeding. Endoscopy (2008) 2.45
Medical-legal risks of incident cancers after clearing colonoscopy. Am J Gastroenterol (2001) 2.40
Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancers. The University of Minnesota's Colon Cancer Control Study. Gastroenterology (1989) 2.37
Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg (1997) 2.21
The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br J Surg (1985) 2.20
Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med (1996) 2.14
Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology (1996) 2.01
Volume, composition, and source of intestinal gas. Gastroenterology (1970) 1.97
The role of intestinal gas in functional abdominal pain. N Engl J Med (1975) 1.85
Quantitative measurement of lactose absorption. Gastroenterology (1976) 1.79
Sequential changes of plasma proteins after surgical trauma. Scand J Clin Lab Invest Suppl (1972) 1.77
Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med (1995) 1.75
Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology (1996) 1.68
Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial. Gut (2001) 1.63
Self rating of health is associated with stressful life events, social support and residency in East and West Berlin shortly after the fall of the wall. J Epidemiol Community Health (2000) 1.60
Histopathological analysis of benign polyps in patients with carcinoma of the colon and rectum. Gut (1974) 1.57
Carcinoma of the colon and rectum in a defined population. An epidemiological, clinical and postmortem investigation of colorectal carcinoma and coexisting benign polyps in Malmö, Sweden. Acta Chir Scand Suppl (1973) 1.52
[Is Campylobacter pylori more frequently observed after antisecretory treatment]. Gastroenterol Clin Biol (1988) 1.49
Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International Collaborative Group on HNPCC. Cancer (1998) 1.48
Small flat adenomas appear to have little clinical importance in Western countries. Gastrointest Endosc (1995) 1.47
The National Polyp Study. Design, methods, and characteristics of patients with newly diagnosed polyps. The National Polyp Study Workgroup. Cancer (1992) 1.46
Colon capsule endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy (2012) 1.42
Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany. Eur J Cancer Prev (1993) 1.41
Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial. Cancer (1986) 1.40
Prediction of the effects and costs of breast-cancer screening in Germany. Int J Cancer (1994) 1.40
Microchimerism: a stable state of low-ratio proliferation of allogeneic bone marrow. Transplant Proc (1977) 1.39
Early diagnosis of colorectal cancer: a review. J R Soc Med (1984) 1.37
Colonic conservation of malabsorbed carbohydrate. Gastroenterology (1980) 1.35
Use of breath hydrogen (H2) to quantitate small bowel transit time following partial gastrectomy. J Lab Clin Med (1977) 1.34
Fate of soluble carbohydrate in the colon of rats and man. J Clin Invest (1976) 1.31
The InSiGHT database: utilizing 100 years of insights into Lynch syndrome. Fam Cancer (2013) 1.27
Swallow syncope. Can Med Assoc J (1985) 1.24
Hydrogen (H2) catabolism in the colon of the rat. J Lab Clin Med (1974) 1.22
The value of intensive follow-up after curative resection for colorectal carcinoma. Br J Surg (1982) 1.22
Use of glyceryl trinitrate ointment in the treatment of anal fissure. Br J Surg (1996) 1.20
Transanal endoscopic microsurgery--initial experience from three centres in the United Kingdom. Br J Surg (1996) 1.20
Ulcerative colitis and indeterminate colitis in the city of Malmö, Sweden. A 25-year incidence study. Scand J Gastroenterol (1995) 1.20
[Screening for colorectal cancer with the Haemoccult test (author's transl)]. Leber Magen Darm (1977) 1.17
[Do female medical graduates have different views on professional work and workload compared to their male colleagues? Results of a multicenter postal survey in Germany]. Dtsch Med Wochenschr (2012) 1.16
Use of breath hydrogen (H2) in the study of carbohydrate absorption. Am J Dig Dis (1977) 1.14
[Treatment of rectal cancer with the neodymium-YAG laser]. Gastroenterol Clin Biol (1986) 1.14
A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol (2000) 1.13
Gastrointestinal transit in thyroid disease. Gastroenterology (1984) 1.13
Blood-brain neutral amino acid transport activity is increased after portacaval anastomosis. Science (1978) 1.11
Colon "cast" in a patient with ischaemic colitis. Br J Surg (1987) 1.10
Gaseousness and intestinal gas. Med Clin North Am (1978) 1.10
Liver diseases in asymptomatic carriers of hepatitis B antigen. Gastroenterology (1974) 1.09
Multiple antibiotic resistance in clinical strains of Neisseria gonorrhoeae isolated in South Carolina. Antimicrob Agents Chemother (1976) 1.09
Recurrence rate after surgical treatment of Crohn's disease. Scand J Gastroenterol (1983) 1.08
ACPGBI position statement on elective resection for diverticulitis. Colorectal Dis (2011) 1.07
The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients. J Nucl Med (1985) 1.07
Endoscopic ultrasonography in chronic pancreatitis: a comparative prospective study with conventional ultrasonography, computed tomography, and ERCP. Pancreas (1995) 1.07
Association of antigen expression and DNA ploidy in human colorectal tumors. Cancer Res (1986) 1.06
Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis. Endoscopy (2009) 1.06
Picking up the tab: obstruction of the gastrointestinal tract by plastic bread bag clips. Gastrointest Endosc (1985) 1.05
Immunological defect in Whipple's disease. Gastroenterology (1972) 1.05
Added value of narrow band imaging and confocal laser endomicroscopy in detecting Barrett's esophagus neoplasia. Endoscopy (2012) 1.04
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients. Cancer Immunol Immunother (2003) 1.04
Prevention of colorectal cancer: guidelines based on new data. WHO Collaborating Center for the Prevention of Colorectal Cancer. Bull World Health Organ (1995) 1.03
Early morbidity of endoscopic ultrasound: 13 years' experience at a referral center. Endoscopy (2006) 1.02
A graphic method of estimating the specificity of screening programmes from incomplete follow-up data. Methods Inf Med (1987) 1.02
Role of EUS in the management of pancreatic and ampullary carcinoma: a prospective study assessing resectability and prognosis. Gastrointest Endosc (1999) 1.02
Intraduodenal free fatty acids rather than triglycerides are responsible for the release of CCK in humans. Pancreas (1997) 1.02
Amiodarone hepatotoxicity simulating alcoholic liver disease. N Engl J Med (1984) 1.01
Follow-up of patients with hyperplastic polyps of the large bowel. Gastrointest Endosc (1997) 1.00
Partial resection and fenestration in the treatment of polycystic liver disease. Br J Surg (1984) 1.00
Antigenicity of newly established colorectal carcinoma cell lines. Br J Cancer (1986) 1.00
Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression. Br J Cancer (1987) 1.00
Methylation of the adenomatous polyposis coli (APC) gene in human placenta and hypermethylation in choriocarcinoma cells. Cancer Lett (2008) 1.00
Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer. Br J Cancer (1998) 0.99
An updated mutation spectrum in an Australian series of PJS patients provides further evidence for only one gene locus. Clin Genet (2006) 0.99
[Screening tests for colon cancer - a new comparison Haemoccult - hemoFEC and review of 9 years clinical experience with Haemoccult (author's transl)]. Z Gastroenterol (1982) 0.98
Large genomic alterations in hMSH2 and hMLH1 in early-onset colorectal cancer: identification of a large complex de novo hMLH1 alteration. Clin Genet (2006) 0.98
Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group. Gut (2005) 0.98
The localization of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumours. Br J Surg (1984) 0.97
Approach to the jaundiced patient. Gastroenterology (1983) 0.97
RNA-based mutation screening in hereditary nonpolyposis colorectal cancer. Am J Hum Genet (1996) 0.96
Single dose doxycycline prophylaxis and peroperative bacteriological culture in elective colorectal surgery. Br J Surg (1981) 0.96
Rectal passage of intestinal endometriosis. Dig Dis Sci (2001) 0.95
Flatulence. Annu Rev Med (1980) 0.95